BICARBONATE REKOVAL DURING ACETATE HEKODIALYSIS AND ITS POSSIBLE USE IN RESPIRATORY FAILURE OF THE NEWBORN :
ANIKAL STUDIES ON EXTRACORPOREAL BICARBONATE/COz-REKOVAL (ecBICC0zR) AND APNEIC OXYGENATION S . Nolte, U. Jonitz, J. Grau and E. Assenbaum Univ.-Kinderklinik, Eathildenstr.1 D -7800 Freibura Extracorporeal techniques for respiratory support in the newborn are ffasiblf and established as neonatal extracorporeal membrane oxygenation (ECXO) . It has been shown however. that even in severly damaged lungs, sufficient oxygenation (apneic oxygenation) can bs maintained by only removing COz with an artificial lung, a technique called extracorporeal .
During routine acetate hemodialysis in 22 patients with end stage renal disease an overall COz-removal of 79.1 +/-15.1 ml was measured, at least one third of the entire metabolic COz -production. For total metabolic COz-removal, acetate dialysate (221nrnol/l) was modified with phosphate buffer (Zmmol/l), lactate (51nmol/l) and sodium hydroxide (7mmolll) to compensate for ths bic~rbonate loss. In 6 sheep, apneic oxygenation could be achieved with blood flow rates as low as 10-15 ml/kg/~nin for 4-6 hours.
These data suggest that a hemodialysis procedure for bicarbonate and COzelimination (ecBICCOzR) is an efficient method for COz-removal necessitating much lower blood flow rates than other tkchniques presently used. An other advantage of this t~chniquf is the maintainence of acid-base, electrolyte and fluid balanca as riel1 as renal replacement in multiple organ failure. The pathogenesis of vit A enbrycpathy is unclear. This study was performed in order to gain insiqht into possible mechanisms involved. Vit A (Pquasol A) 50,mO U or salire were administered int mgastrimlly to pregnant (day 9: day C= sperm detected) rats. Vit A treatrent of 22 pregnant rats was associatecl with 65.8"af a h o m l fetuses examined on day 20. Retinol (R) and R metablites were analyzed by H P W in rat conceptuses on days 10 and 11 follming the s a m treatments. While no R or R mtabolites were detected in control conceptuses, traces of R and a large peak (with KI' corresponding to Ret palm) were observed in h w e n a t e extracts of conceptuses at both ages examined. Treatmnt of these extracts with 1M ethanolic KOH resulted in a single large R peak and disappmmnce of the Ret palm W. It has been suggested that retinyl esters are related to vit A toxicity. Contrary to the well regulated passage of vit A across the placenta at lmer doses, follming very large doses to the pregnant nnther vit A reaches a h o m l l y high concentrations and at an earlier age in conceptus. Ret palm m y play a role in the pathogenesis of experitrental vit A &ryopathy.
LYSlNURlC PROTEIN INTOLERANCE (LPI):
A POSSIBLE vs. r=0.206f0.007, n=7: pc0.02).
Therefore, the LDL fraction seems to be mainly responsible for the increase of PBL membrane fluidity in DMD patients. Institutions, P&cs, Hungary skiere malformatio'ns of dermal ridges among index cases made quantitative analysis inaccesible and therefore only qualitative dermatoglyphic parameters were examined. The most significant derrnatoglyphic patterns of hands and feet which differentiated the patients f r m the controls were as follows: 1. significantly higher frequency of arches on the fingertips (boys: 31.4% vs 2.4%; girls: 15% vs 6%), 2. higher frequency of arches on the toetips (boys: 45.7% vs 11.7%; girls: 30% vs 16.4%),
3. absence of whorls on the finger and toetips, 4. increased incidence of double or ulnar loops in the hypothenar area (boys: 78.5% vs 13.0%; girls: 100% vs 15.5%), 5. significant increase in the incidence of Sydney line on the hands (boys: 56.2% vs 2.0%; girls: 50% vs 6%), 6. severe ridges malformations revealing a characteristic appearance of "ridge hypoplasia" or "ridge dissociation".
Valproate (VPA) is known to cause carnitine (C) deficiency. lo children receiving chronic VPA treatment were given equimolar C (1.2 mg C/mg VPA) concomitantly for 14 days. The plasma level ofphydroxybutyrate was lower in VPA treated children than in the fontrol subjects (31.8-7.4 vs 90.0'21.4 nmol/ml, means-SEM, p<o.o5),wh)ch remained unchanged after the C treatment (29.7-7.1), showing that the C was not able in itself to improve the plasma ketone level. The plasma level of FFA, triglycerides and cholesterol remained unaffected by C treatment, the level of HDL cholesterol decreased in the supplemented group. The daily fxcreted qotal N was not affected by C treatment (6.0 -0.5, 7.3-0.3 and 7.3+1. o g/day; day 0, 14 and control subjects) with no changes of excreted urea and ammonia suggesting,that the organism does not utilize ?,roteins (and/or amino acids) as alternative fuels :nstead of ketone bodies during VPA treatment.
